feed,title,long_url,short_url
MX,RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population,https://medicalxpress.com/news/2022-09-ret-inhibitor-selpercatinib-durable-responses.html,https://bit.ly/3L85qVK
